Darden Douglas, Peterson Pamela N, Xin Xin, Munir Muhammad Bilal, Minges Karl E, Goldenberg Ilan, Poole Jeanne E, Feld Gregory K, Birgersdotter-Green Ulrika, Curtis Jeptha P, Hsu Jonathan C
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California, San Diego, La Jolla, California.
Division of Cardiology, Denver Health Medical Center, Denver, Colorado.
Heart Rhythm O2. 2022 Apr 2;3(4):405-414. doi: 10.1016/j.hroo.2022.03.004. eCollection 2022 Aug.
Contemporary data on national trends and outcomes in cardiac resynchronization therapy with defibrillator (CRT-D) recipients following the 2012 updated guidelines has not been studied.
This study assessed the trends in long-term outcomes among CRT-D Medicare-aged recipients implanted in 2011-2015.
Patients aged ≥65 years undergoing de novo CRT-D implantation in the National Cardiovascular Data Implantable Cardiac Defibrillator Registry from 2011-2015 with follow-up through 2017 using Medicare data were included and stratified by year of implant. Patient characteristics, in-hospital outcomes, and outcomes up to 2 years following implant were evaluated.
Among 53,174 patients (aged 75.6-6.4 years, 29.7% women) implanted with CRT-D from 2011 to 2015, there was an increase in implantations based on guideline-concordant recommendations (81.0% to 84.7%, < .001). Compared to 2011, in-hospital procedural complications decreased in 2015 (3.9% vs 2.9%; adjusted odds ratio, 0.76, 95% confidence interval, 0.66-0.88, < .001), driven in part by decreased lead dislodgement (1.4% vs 1.0%). After multivariable adjustment, there was a lower risk of all-cause hospitalization, cardiovascular hospitalization, and mortality at 2-year follow-up in 2015 as compared to 2011, while there were no differences in heart failure hospitalizations at follow-up.
Among Medicare beneficiaries receiving CRT-D from 2011 to 2015, there was an increase in implantations based on guideline-concordant recommendations. Furthermore, there has been a reduction in in-hospital complications and long-term outcomes, including cardiovascular hospitalization, all-cause hospitalization, and mortality; however, there has been no difference in the risk of heart failure hospitalization after adjustment.
2012年更新指南发布后,关于心脏再同步化治疗除颤器(CRT-D)植入患者的全国趋势和治疗结果的当代数据尚未得到研究。
本研究评估了2011 - 2015年植入CRT-D的医疗保险年龄患者的长期治疗结果趋势。
纳入2011 - 2015年在国家心血管数据植入式心脏除颤器登记处接受初次CRT-D植入且使用医疗保险数据随访至2017年的年龄≥65岁的患者,并按植入年份进行分层。评估患者特征、住院期间结局以及植入后长达2年的结局。
在2011年至2015年植入CRT-D的53174例患者(年龄75.6±6.4岁,29.7%为女性)中,基于符合指南的推荐进行的植入手术有所增加(从81.0%增至84.7%,P<0.001)。与2011年相比,2015年住院期间手术并发症有所减少(3.9%对2.9%;调整后的优势比为0.76,95%置信区间为0.66 - 0.88,P<0.001),部分原因是导线脱位减少(1.4%对1.0%)。多变量调整后,与2011年相比,2015年2年随访时全因住院、心血管住院和死亡风险较低,而随访时心力衰竭住院情况无差异。
在2011年至2015年接受CRT-D治疗的医疗保险受益人中,基于符合指南的推荐进行的植入手术有所增加。此外,住院并发症和包括心血管住院、全因住院和死亡在内的长期治疗结果有所改善;然而,调整后心力衰竭住院风险无差异。